Publications by authors named "Shushan Guo"

Claim this Profile
C
Corrigendum to "Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma" [Arch. Biochem. Biophys. 754 (2024) 109929].
Yue Lai, Shushan Guo, Qiongwei Tang, Gaomei Chang, Hui Zhang

Arch Biochem Biophys· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant activation of adenine nucleotide translocase 3 promotes progression and chemoresistance in multiple myeloma dependent on PINK1 transport.
Ke Hu, Yue Lai, Jinfeng Zhou, Chaolu Hu, Shushan Guo

Int J Biol Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and biological evaluation of novel 1-amido-2-one-4-thio-deoxypyranose as potential antitumor agents for multiple myeloma.
Xiaomei Li, Hui Zhang, Sanfeng Dong, Xuejie Gao, Haiguo Sun, Shushan Guo, Zhufeng Guo

Bioorg Med Chem· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EZH2 inhibition induces senescence via ERK1/2 signaling pathway in multiple myeloma.
Shushan Guo, Qiongwei Tang, Xuejie Gao, Liangning Hu, Ke Hu

Acta Biochim Biophys Sin (Shanghai)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma.
Yue Lai, Shushan Guo, Qiongwei Tang, Gaomei Chang, Hui Zhang

Arch Biochem Biophys· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular mechanism by which RRM2-inhibitor (cholagogue osalmid) plus bafilomycin A1 cause autophagic cell death in multiple myeloma.
Shushan Guo, Zhijian Xu, Qilin Feng, Hui Zhang, Dandan Yu

Arch Biochem Biophys· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma.
Li Xu, Yingcong Wang, Guanli Wang, Shushan Guo, Dandan Yu

Leukemia· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis